trending Market Intelligence /marketintelligence/en/news-insights/trending/jgQFmqWDfyuBOgF9EmvNlw2 content esgSubNav
In This List

Illumina's chief medical officer joins Varian Medical's board

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Illumina's chief medical officer joins Varian Medical's board

Illumina Inc.'s Chief Medical Officer Phil Febbo was appointed to Varian Medical Systems Inc.'s board, effective Aug. 16.

Febbo has been serving as San Diego-based Illumina's chief medical officer since 2018 and has been responsible for developing and executing the company's medical strategy.

Palo Alto, Calif.-based medical-device maker Varian said in an SEC filing that prior to joining Illumina, Febbo served as chief medical officer of Genomic Health Inc. for five years.